Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 2
2020 4
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Clinically relevant drug interactions between statins and antidepressants.
Palleria C, Roberti R, Iannone LF, Tallarico M, Barbieri MA, Vero A, Manti A, De Sarro G, Spina E, Russo E. Palleria C, et al. Among authors: manti a. J Clin Pharm Ther. 2020 Apr;45(2):227-239. doi: 10.1111/jcpt.13058. Epub 2019 Oct 6. J Clin Pharm Ther. 2020. PMID: 31587356 Review.
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice.
Roberti R, Iannone LF, Palleria C, Curcio A, Rossi M, Sciacqua A, Armentaro G, Vero A, Manti A, Cassano V, Russo E, De Sarro G, Citraro R. Roberti R, et al. Among authors: manti a. Front Pharmacol. 2021 May 26;12:684638. doi: 10.3389/fphar.2021.684638. eCollection 2021. Front Pharmacol. 2021. PMID: 34122113 Free PMC article. Review.
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study.
Iannone LF, Bennardo L, Palleria C, Roberti R, De Sarro C, Naturale MD, Dastoli S, Donato L, Manti A, Valenti G, D'Amico D, D'Attola S, De Francesco AE, Bosco V, Donato Di Paola E, Nisticò SP, Citraro R, Russo E, De Sarro G. Iannone LF, et al. Among authors: manti a. PLoS One. 2020 Nov 3;15(11):e0241575. doi: 10.1371/journal.pone.0241575. eCollection 2020. PLoS One. 2020. PMID: 33141869 Free PMC article.
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy.
Roberti R, Iannone LF, Palleria C, De Sarro C, Spagnuolo R, Barbieri MA, Vero A, Manti A, Pisana V, Fries W, Trifirò G, Naturale MD, Larussa T, De Francesco AE, Bosco V, Donato di Paola E, Citraro R, Luzza F, Bennardo L, Rodinò S, Doldo P, Spina E, Russo E, De Sarro G. Roberti R, et al. Among authors: manti a. Curr Med Res Opin. 2020 Sep;36(9):1457-1463. doi: 10.1080/03007995.2020.1786681. Epub 2020 Jul 27. Curr Med Res Opin. 2020. PMID: 32573307
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP).
Palleria C, Iannone L, Leporini C, Citraro R, Manti A, Caminiti M, Gigliotti P, Grembiale RD, L'Andolina M, Muccari G, Naturale MD, Olivo D, Pagano Mariano G, Pellegrini R, Varcasia G, Abdalla K, Russo E, Ursini F, De Sarro G. Palleria C, et al. Among authors: manti a. PLoS One. 2018 Oct 24;13(10):e0205134. doi: 10.1371/journal.pone.0205134. eCollection 2018. PLoS One. 2018. PMID: 30356301 Free PMC article.